BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24092818)

  • 1. Epoxyeicosatrienoic acids prevent cisplatin-induced renal apoptosis through a p38 mitogen-activated protein kinase-regulated mitochondrial pathway.
    Liu Y; Lu X; Nguyen S; Olson JL; Webb HK; Kroetz DL
    Mol Pharmacol; 2013 Dec; 84(6):925-34. PubMed ID: 24092818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling.
    Liu Y; Webb HK; Fukushima H; Micheli J; Markova S; Olson JL; Kroetz DL
    J Pharmacol Exp Ther; 2012 Jun; 341(3):725-34. PubMed ID: 22414856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Alkoxy- Analogues of Epoxyeicosatrienoic Acids Attenuate Cisplatin Nephrotoxicity In Vitro via Reduction of Mitochondrial Dysfunction, Oxidative Stress, Mitogen-Activated Protein Kinase Signaling, and Caspase Activation.
    Singh N; Vik A; Lybrand DB; Morisseau C; Hammock BD
    Chem Res Toxicol; 2021 Dec; 34(12):2579-2591. PubMed ID: 34817988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy.
    Chen G; Xu R; Wang Y; Wang P; Zhao G; Xu X; Gruzdev A; Zeldin DC; Wang DW
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E563-75. PubMed ID: 22739108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in soluble epoxide hydrolase (sEH) during cisplatin-induced acute renal failure in mice.
    Hashimoto T; Fang YI; Ohata H; Honda K
    J Toxicol Sci; 2015 Aug; 40(4):451-7. PubMed ID: 26165641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity.
    Khan MA; Liu J; Kumar G; Skapek SX; Falck JR; Imig JD
    FASEB J; 2013 Aug; 27(8):2946-56. PubMed ID: 23603837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate reduces cisplatin-induced apoptosis of renal proximal tubular cells via inhibition of JNK and p38 pathways.
    Thongnuanjan P; Soodvilai S; Chatsudthipong V; Soodvilai S
    J Toxicol Sci; 2016; 41(3):339-49. PubMed ID: 27193727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
    Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S
    Cell Death Dis; 2019 May; 10(5):355. PubMed ID: 31043583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.
    Noh MR; Jang HS; Salem FE; Ferrer FA; Kim J; Padanilam BJ
    Am J Physiol Renal Physiol; 2023 Feb; 324(2):F138-F151. PubMed ID: 36475868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy.
    Jiang XS; Xiang XY; Chen XM; He JL; Liu T; Gan H; Du XG
    Cell Death Dis; 2020 May; 11(5):385. PubMed ID: 32439839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide.
    Liu L; Chen C; Gong W; Li Y; Edin ML; Zeldin DC; Wang DW
    J Pharmacol Exp Ther; 2011 Nov; 339(2):451-63. PubMed ID: 21846841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrate prevents cisplatin-induced proximal tubule cell death.
    Nagothu KK; Bhatt R; Kaushal GP; Portilla D
    Kidney Int; 2005 Dec; 68(6):2680-93. PubMed ID: 16316343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis.
    Kuo YM; Hsu PC; Hung CC; Hu YY; Huang YJ; Gan YL; Lin CH; Shie FS; Chang WK; Kao LS; Tsou MY; Lee YH
    Mol Neurobiol; 2019 Dec; 56(12):8451-8474. PubMed ID: 31257558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model.
    Chen L; Fan C; Zhang Y; Bakri M; Dong H; Morisseau C; Maddipati KR; Luo P; Wang CY; Hammock BD; Wang MH
    Prostaglandins Other Lipid Mediat; 2013; 104-105():42-8. PubMed ID: 23247129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.
    Liang Y; Jing Z; Deng H; Li Z; Zhuang Z; Wang S; Wang Y
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):70-5. PubMed ID: 25986738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.
    Revermann M; Barbosa-Sicard E; Dony E; Schermuly RT; Morisseau C; Geisslinger G; Fleming I; Hammock BD; Brandes RP
    J Hypertens; 2009 Feb; 27(2):322-31. PubMed ID: 19226702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
    Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
    Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis.
    Trindade-da-Silva CA; Bettaieb A; Napimoga MH; Lee KSS; Inceoglu B; Ueira-Vieira C; Bruun D; Goswami SK; Haj FG; Hammock BD
    J Pharmacol Exp Ther; 2017 Jun; 361(3):408-416. PubMed ID: 28356494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR-δ activation reduces cisplatin-induced apoptosis via inhibiting p53/Bax/caspase-3 pathway without modulating autophagy in murine renal proximal tubular cells.
    Shan J; Kimura H; Yokoi S; Kamiyama K; Imamoto T; Takeda I; Kobayashi M; Mikami D; Takahashi N; Kasuno K; Sugaya T; Iwano M
    Clin Exp Nephrol; 2021 Jun; 25(6):598-607. PubMed ID: 33646450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective roles of thrombomodulin in cisplatin-induced nephrotoxicity through the inhibition of oxidative and endoplasmic reticulum stress.
    Yamamoto H; Ishida Y; Zhang S; Osako M; Nosaka M; Kuninaka Y; Ishigami A; Iwahashi Y; Aragane M; Matsumoto L; Kimura A; Kondo T
    Sci Rep; 2024 Jun; 14(1):14004. PubMed ID: 38890434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.